Seguir
Ecevit Bilgili
Título
Citado por
Citado por
Año
Bioavailability enhancement of poorly water-soluble drugs via nanocomposites: Formulation–Processing aspects and challenges
A Bhakay, M Rahman, RN Dave, E Bilgili
Pharmaceutics 10 (3), 86, 2018
2222018
Nanomilling of drugs for bioavailability enhancement: a holistic formulation-process perspective
M Li, M Azad, R Davé, E Bilgili
Pharmaceutics 8 (2), 17, 2016
2122016
Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications
L Sievens-Figueroa, A Bhakay, JI Jerez-Rozo, N Pandya, RJ Romañach, ...
International journal of pharmaceutics 423 (2), 496-508, 2012
2062012
Population balance modeling of non-linear effects in milling processes
E Bilgili, B Scarlett
Powder Technology 153 (1), 59-71, 2005
1882005
Scale-up of pharmaceutical spray drying using scale-up rules: A review
S Poozesh, E Bilgili
International Journal of Pharmaceutics 562, 271-292, 2019
1832019
Novel aspects of wet milling for the production of microsuspensions and nanosuspensions of poorly water-soluble drugs
A Bhakay, M Merwade, E Bilgili, RN Dave
Drug development and industrial pharmacy 37 (8), 963-976, 2011
1552011
Nano-milling of pigment agglomerates using a wet stirred media mill: Elucidation of the kinetics and breakage mechanisms
E Bilgili, R Hamey, B Scarlett
Chemical engineering science 61 (1), 149-157, 2006
1432006
Impact of process parameters on the breakage kinetics of poorly water-soluble drugs during wet stirred media milling: A microhydrodynamic view
A Afolabi, O Akinlabi, E Bilgili
European journal of pharmaceutical sciences 51, 75-86, 2014
1372014
A combined microhydrodynamics–polymer adsorption analysis for elucidation of the roles of stabilizers in wet stirred media milling
E Bilgili, A Afolabi
International journal of pharmaceutics 439 (1-2), 193-206, 2012
1322012
Continuous production of drug nanoparticle suspensions via wet stirred media milling: a fresh look at the Rehbinder effect
A Monteiro, A Afolabi, E Bilgili
Drug development and industrial pharmacy 39 (2), 266-283, 2013
1092013
A study of the physical stability of wet media-milled fenofibrate suspensions using dynamic equilibrium curves
C Knieke, MA Azad, RN Davé, E Bilgili
Chemical Engineering Research and Design 91 (7), 1245-1258, 2013
1052013
Sub-100 nm drug particle suspensions prepared via wet milling with low bead contamination through novel process intensification
M Li, N Yaragudi, A Afolabi, R Dave, E Bilgili
Chemical Engineering Science 130, 207-220, 2015
1002015
Pulverization of rubber granulates using the solid state shear extrusion process: Part II. Powder characterization
E Bilgili, H Arastoopour, B Bernstein
Powder Technology 115 (3), 277-289, 2001
932001
Formulation of a non-linear framework for population balance modeling of batch grinding: Beyond first-order kinetics
E Bilgili, J Yepes, B Scarlett
Chemical Engineering Science 61 (1), 33-44, 2006
892006
Pulverization of rubber granulates using the solid-state shear extrusion (SSSE) process:: Part I. Process concepts and characteristics
E Bilgili, H Arastoopour, B Bernstein
Powder Technology 115 (3), 265-276, 2001
892001
Using USP I and USP IV for discriminating dissolution rates of nano-and microparticle-loaded pharmaceutical strip-films
L Sievens-Figueroa, N Pandya, A Bhakay, G Keyvan, B Michniak-Kohn, ...
Aaps Pharmscitech 13, 1473-1482, 2012
852012
Production of pigment nanoparticles using a wet stirred mill with polymeric media
E Bilgili, R Hamey, B Scarlett
China Particuology 2 (3), 93-100, 2004
842004
Recovery of BCS Class II drugs during aqueous redispersion of core–shell type nanocomposite particles produced via fluidized bed coating
A Bhakay, R Davé, E Bilgili
Powder technology 236, 221-234, 2013
772013
Preparation and characterization of fast dissolving pullulan films containing BCS class II drug nanoparticles for bioavailability enhancement
SM Krull, Z Ma, M Li, RN Davé, E Bilgili
Drug development and industrial pharmacy 42 (7), 1073-1085, 2016
752016
Is the combination of cellulosic polymers and anionic surfactants a good strategy for ensuring physical stability of BCS Class II drug nanosuspensions?
E Bilgili, M Li, A Afolabi
Pharmaceutical Development and Technology 21 (4), 499-510, 2016
752016
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20